173 related articles for article (PubMed ID: 36864382)
21. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
[TBL] [Abstract][Full Text] [Related]
22. Extracellular miRNA-21 as a novel biomarker in glioma: Evidence from meta-analysis, clinical validation and experimental investigations.
Qu K; Lin T; Pang Q; Liu T; Wang Z; Tai M; Meng F; Zhang J; Wan Y; Mao P; Dong X; Liu C; Niu W; Dong S
Oncotarget; 2016 Jun; 7(23):33994-4010. PubMed ID: 27166186
[TBL] [Abstract][Full Text] [Related]
23. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
Wang Q; Li P; Li A; Jiang W; Wang H; Wang J; Xie K
J Exp Clin Cancer Res; 2012 Nov; 31(1):97. PubMed ID: 23174013
[TBL] [Abstract][Full Text] [Related]
24. Serum MicroRNA-Based Risk Prediction for Stroke.
Sonoda T; Matsuzaki J; Yamamoto Y; Sakurai T; Aoki Y; Takizawa S; Niida S; Ochiya T
Stroke; 2019 Jun; 50(6):1510-1518. PubMed ID: 31136284
[TBL] [Abstract][Full Text] [Related]
25. Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.
Li Z; Ye L; Wang L; Quan R; Zhou Y; Li X
Ann Diagn Pathol; 2020 Feb; 44():151436. PubMed ID: 31865249
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNAs in gallbladder cancer: Is serum assay of diagnostic value?
Srivastava P; Mishra S; Agarwal A; Pandey A; Husain N
Pathol Res Pract; 2023 Feb; 242():154320. PubMed ID: 36682281
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.
Ma C; Nguyen HPT; Luwor RB; Stylli SS; Gogos A; Paradiso L; Kaye AH; Morokoff AP
PLoS One; 2018; 13(2):e0189452. PubMed ID: 29444091
[TBL] [Abstract][Full Text] [Related]
28. A novel combination of serum microRNAs for the detection of early gastric cancer.
Abe S; Matsuzaki J; Sudo K; Oda I; Katai H; Kato K; Takizawa S; Sakamoto H; Takeshita F; Niida S; Saito Y; Ochiya T
Gastric Cancer; 2021 Jul; 24(4):835-843. PubMed ID: 33743111
[TBL] [Abstract][Full Text] [Related]
29. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
30. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
Zhang Y; Zhang Y; Yin Y; Li S
Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
[TBL] [Abstract][Full Text] [Related]
31. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
32. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
33. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
Wei X; Chen D; Lv T; Li G; Qu S
Mol Neurobiol; 2016 Jan; 53(1):163-170. PubMed ID: 25416859
[TBL] [Abstract][Full Text] [Related]
34. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
35. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma.
Si PP; Zhou XH; Qu ZZ
J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
[TBL] [Abstract][Full Text] [Related]
36. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis.
Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W
Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019
[TBL] [Abstract][Full Text] [Related]
37. A novel serum microRNA-based identification and classification biomarker of human glioma.
Xing W; Zeng C
Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
[TBL] [Abstract][Full Text] [Related]
38. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
39. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
[TBL] [Abstract][Full Text] [Related]
40. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
